Pagano Tathiana, Matsutani Luciana Akemi, Ferreira Elisabeth Alves Gonçalves, Marques Amélia Pasqual, Pereira Carlos Alberto de Bragança
Rheumatology clinic, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Sao Paulo Med J. 2004 Nov 4;122(6):252-8. doi: 10.1590/s1516-31802004000600005. Epub 2005 Feb 2.
Fibromyalgia is a syndrome characterized by chronic, diffuse musculoskeletal pain, and by a low pain threshold at specific anatomical points. The syndrome is associated with other symptoms such as fatigue, sleep disturbance, morning stiffness and anxiety. Because of its chronic nature, it often has a negative impact on patients' quality of life.
To assess the quality of life and anxiety level of patients with fibromyalgia.
Cross-sectional.
Rheumatology outpatient service of Hospital das Clínicas (Medical School, Universidade de São Paulo).
This study evaluated 80 individuals, divided between test and control groups. The test group included 40 women with a confirmed diagnosis of fibromyalgia. The control group was composed of 40 healthy women. Three questionnaires were used: two to assess quality of life (FIQ and SF-36) and one to assess anxiety (STAI). They were applied to the individuals in both groups in a single face-to-face interview. The statistical analysis used Student's t test and Pearson's correlation test (r), with a significance level of 95%. Also, the Pearson chi-squared statistics test for homogeneity, with Yates correction, was used for comparing schooling between test and control groups.
There was a statistically significant difference between the groups (p = 0.000), thus indicating that fibromyalgia patients have a worse quality of life and higher levels of anxiety. The correlations between the three questionnaires were high (r = 0.9).
This study has confirmed the efficacy of FIQ for evaluating the impact of fibromyalgia on the quality of life. SF-36 is less specific than FIQ, although statistically significant values were obtained when analyzed separately, STAI showed lower efficacy for discriminating the test group from the control group. The test group showed worse quality of life than did the control group, which was demonstrated by both FIQ and SF-36. Even though STAI was a less efficient instrument, it presented significant results, showing that fibromyalgia patients presented higher levels of anxiety, both on the state and trait scales. Thus, patients with fibromyalgia had higher levels of tension, nervousness, preoccupation and apprehension, and higher propensity towards anxiety.
The three instruments utilized showed efficiency in evaluating fibromyalgia patients. FIQ was found to be the most efficient instrument for discriminating and assessing the impact of fibromyalgia on their quality of life. It can be concluded that such patients have a worse quality of life and higher levels of anxiety.
纤维肌痛是一种以慢性、弥漫性肌肉骨骼疼痛以及特定解剖部位疼痛阈值低为特征的综合征。该综合征还伴有疲劳、睡眠障碍、晨僵和焦虑等其他症状。由于其慢性性质,它常常对患者的生活质量产生负面影响。
评估纤维肌痛患者的生活质量和焦虑水平。
横断面研究。
圣保罗大学医学院临床医院的风湿病门诊。
本研究评估了80名个体,分为试验组和对照组。试验组包括40名确诊为纤维肌痛的女性。对照组由40名健康女性组成。使用了三份问卷:两份用于评估生活质量(FIQ和SF - 36),一份用于评估焦虑(STAI)。它们在一次面对面访谈中应用于两组个体。统计分析采用学生t检验和皮尔逊相关检验(r),显著性水平为95%。此外,使用带耶茨校正的皮尔逊卡方同质性统计检验来比较试验组和对照组之间的受教育程度。
两组之间存在统计学上的显著差异(p = 0.000),这表明纤维肌痛患者的生活质量更差,焦虑水平更高。三份问卷之间的相关性很高(r = 0.9)。
本研究证实了FIQ在评估纤维肌痛对生活质量影响方面的有效性。SF - 36的特异性低于FIQ,尽管单独分析时获得了具有统计学意义的值,但STAI在区分试验组和对照组方面显示出较低的有效性。试验组的生活质量比对照组差,这在FIQ和SF - 36中均得到证明。尽管STAI是一种效率较低的工具,但它呈现出显著的结果,表明纤维肌痛患者在状态和特质量表上的焦虑水平都更高。因此,纤维肌痛患者的紧张、焦虑、担忧和恐惧水平更高,且更易出现焦虑倾向。
所使用的三种工具在评估纤维肌痛患者方面显示出有效性。发现FIQ是区分和评估纤维肌痛对其生活质量影响的最有效工具。可以得出结论,此类患者的生活质量更差,焦虑水平更高。